Xiaohui Lin

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Metabolic Syndrome

Circulating Tumor

Antiretroviral Therapy

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Proceedings of the National Academy of Sciences of the United States of America

Science advances

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marie-France Langelier, Xiaohui Lin, Shan Zha, John M Pascal
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA. Science advances 9 (12) (2023)
Zhengping Shao, Brian J Lee, Hanwen Zhang, Xiaohui Lin, Chen Li, Wenxia Jiang, Napon Chirathivat, Steven Gershik, Michael M Shen, Richard Baer, Shan Zha
Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner. Proceedings of the National Academy of Sciences of the United States of America 120 (31) (2023)
Maja Milanovic, Zhengping Shao, Verna M Estes, Xiaobin S Wang, Demis Menolfi, Xiaohui Lin, Brian J Lee, Jun Xu, Olivia M Cupo, Dong Wang, Shan Zha
FATC Domain Deletion Compromises ATM Protein Stability, Blocks Lymphocyte Development, and Promotes Lymphomagenesis. Journal of immunology (Baltimore, Md. : 1950) 206 (6) (2021)
Xiangyu Liu, Xiaobin S Wang, Brian J Lee, Foon K Wu-Baer, Xiaohui Lin, Zhengping Shao, Verna M Estes, Jean Gautier, Richard Baer, Shan Zha
CtIP is essential for early B cell proliferation and development in mice. The Journal of experimental medicine 216 (7) (2019)
Wenxia Jiang, Verna M Estes, Xiaobin S Wang, Zhengping Shao, Brian J Lee, Xiaohui Lin, Jennifer L Crowe, Shan Zha
Phosphorylation at S2053 in Murine (S2056 in Human) DNA-PKcs Is Dispensable for Lymphocyte Development and Class Switch Recombination. Journal of immunology (Baltimore, Md. : 1950) 203 (1) (2019)